These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1548680)

  • 1. Synthesis and in vitro biological profile of all four isomers of the potent muscarinic agonist 3-(3-methyl-1,2,4-oxadiazol-5-yl)-1-azabicyclo[2.2.1]heptane.
    Showell GA; Baker R; Davis J; Hargreaves R; Freedman SB; Hoogsteen K; Patel S; Snow RJ
    J Med Chem; 1992 Mar; 35(5):911-6. PubMed ID: 1548680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereoisomerism and muscarinic receptor agonists: synthesis and effects of the stereoisomers of 3-[5-(3-amino-1,2,4-oxadiazol)yl]-1- azabicyclo[2.2.1]heptane.
    Pombo-Villar E; Wiederhold KH; Mengod G; Palacios JM; Supavilai P; Boddeke HW
    Eur J Pharmacol; 1992 Aug; 226(4):317-25. PubMed ID: 1397060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and characterization of all four isomers of the muscarinic agonist 2'-methylspiro[1-azabicyclo[2.2.2]octane-3,4'-[1,3]dioxolane].
    Saunders J; Showell GA; Baker R; Freedman SB; Hill D; McKnight A; Newberry N; Salamone JD; Hirshfield J; Springer JP
    J Med Chem; 1987 Jun; 30(6):969-75. PubMed ID: 3585909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-687,306: a functionally selective and potent muscarinic M1 receptor agonist.
    Freedman SB; Patel S; Harley EA; Iversen LL; Baker R; Showell GA; Saunders J; McKnight A; Newberry N; Scholey K
    Eur J Pharmacol; 1992 Apr; 215(1):135-6. PubMed ID: 1516645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and pharmacological evaluation of enantiomerically pure 4-deoxy-4-fluoromuscarines.
    Bravo P; Resnati G; Angeli P; Frigerio M; Viani F; Arnone A; Marucci G; Cantalamessa F
    J Med Chem; 1992 Aug; 35(17):3102-10. PubMed ID: 1507199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel series of non-quaternary oxadiazoles acting as full agonists at muscarinic receptors.
    Freedman SB; Harley EA; Patel S; Newberry NR; Gilbert MJ; McKnight AT; Tang JK; Maguire JJ; Mudunkotuwa NT; Baker R
    Br J Pharmacol; 1990 Nov; 101(3):575-80. PubMed ID: 2076477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resolved pyrrolidine, piperidine, and perhydroazepine analogues of the muscarinic agent N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide.
    Lundkvist JR; Vargas HM; Caldirola P; Ringdahl B; Hacksell U
    J Med Chem; 1990 Dec; 33(12):3182-9. PubMed ID: 2258904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-689,660, a novel cholinomimetic with functional selectivity for M1 and M3 muscarinic receptors.
    Hargreaves RJ; McKnight AT; Scholey K; Newberry NR; Street LJ; Hutson PH; Semark JE; Harley EA; Patel S; Freedman SB
    Br J Pharmacol; 1992 Oct; 107(2):494-501. PubMed ID: 1422595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of 2-(3-substituted-1,2,4-oxadiazol-5-yl)-8-methyl-8-azabicyclo [3.2.1]octanes and 2 alpha-(3-substituted-1,2,4-oxadiazol-5-yl)-8-methyl-8- azabicyclo[3.2.1]oct-2-enes as potential muscarinic agonists.
    Triggle DJ; Kwon YW; Abraham P; Rahman MA; Carroll FI
    Pharm Res; 1992 Nov; 9(11):1474-9. PubMed ID: 1475236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscarinic receptor subtype specificity of (N,N-dialkylamino)alkyl 2-cyclohexyl-2-phenylpropionates: cylexphenes (cyclohexyl-substituted aprophen analogues).
    Leader H; Gordon RK; Baumgold J; Boyd VL; Newman AH; Smejkal RM; Chiang PK
    J Med Chem; 1992 Apr; 35(7):1290-5. PubMed ID: 1560441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and muscarinic receptor activity of ester derivatives of 2-substituted 2-azabicyclo[2.2.1]heptan-5-ol and -6-ol.
    Carroll FI; Abraham P; Chemburkar S; He XC; Mascarella SW; Kwon YW; Triggle DJ
    J Med Chem; 1992 Jun; 35(12):2184-91. PubMed ID: 1613746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and muscarinic activities of 1,2,4-thiadiazoles.
    MacLeod AM; Baker R; Freedman SB; Patel S; Merchant KJ; Roe M; Saunders J
    J Med Chem; 1990 Jul; 33(7):2052-9. PubMed ID: 2362286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereoisomers of N-substituted soft anticholinergics and their zwitterionic metabolite based on glycopyrrolate--syntheses and pharmacological evaluations.
    Wu WM; Wu J; Mori N; Buchwald P; Bodor N
    Pharmazie; 2008 Mar; 63(3):200-9. PubMed ID: 18444508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformationally restricted analogues of the muscarinic agent N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide.
    Lundkvist JR; Ringdahl B; Hacksell U
    J Med Chem; 1989 Apr; 32(4):863-9. PubMed ID: 2704032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological profile of enantiomerically pure chiral muscarinic agonists: desoxymuscarines.
    De Amici M; Dallanoce C; De Micheli C; Angeli P; Marucci G; Cantalamessa F; Sparapassi L
    Life Sci; 2000 Jun; 67(3):317-26. PubMed ID: 10983875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological activity of 1,2,4-oxadiazole derivatives: highly potent and efficacious agonists for cortical muscarinic receptors.
    Street LJ; Baker R; Book T; Kneen CO; MacLeod AM; Merchant KJ; Showell GA; Saunders J; Herbert RH; Freedman SB
    J Med Chem; 1990 Oct; 33(10):2690-7. PubMed ID: 2213823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, molecular modeling studies, and muscarinic receptor activity of azaprophen analogues.
    Triggle DJ; Kwon YW; Abraham P; Pitner JB; Mascarella SW; Carroll FI
    J Med Chem; 1991 Nov; 34(11):3164-71. PubMed ID: 1956033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enantioselectivity of muscarinic antagonists. Isomeric 2-cyclohexyl-2-phenyl-5-[(dimethylamino)methyl]-1,3-oxathiolane methiodides.
    Romanelli MN; Gualtieri F; Valle G; Brasili L; Angeli P
    J Med Chem; 1988 Sep; 31(9):1703-8. PubMed ID: 3411599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The design of novel muscarinic partial agonists that have functional selectivity in pharmacological preparations in vitro and reduced side-effect profile in vivo.
    Freedman SB; Dawson GR; Iversen LL; Baker R; Hargreaves RJ
    Life Sci; 1993; 52(5-6):489-95. PubMed ID: 8441329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enantioselectivity of muscarinic antagonists. 2,2-Dicyclohexyl-5-[(dimethylamino)methyl]-1,3-oxathiolane methiodides and related 3-oxides.
    Romanelli MN; Teodori E; Gualtieri F; Angeli P; Brasili L
    J Med Chem; 1988 Sep; 31(9):1698-702. PubMed ID: 3411598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.